4.6 Article

A novel method for fabrication of coated microneedles with homogeneous and controllable drug dosage for transdermal drug delivery

Journal

DRUG DELIVERY AND TRANSLATIONAL RESEARCH
Volume 12, Issue 11, Pages 2730-2739

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s13346-022-01123-8

Keywords

Coated microneedles; Homogeneous; Controllable; Fabrication process

Funding

  1. National Natural Science Foundation of China [51873015]
  2. Joint Project of BRC-BC (Biomedical Translational Engineering Research Center of BUCT-CJFH) [XK2020-05, RZ2020-01]
  3. Ministry of Finance
  4. Ministry of Education of PRC

Ask authors/readers for more resources

Researchers have developed a mass production method for coated microneedles with homogeneous and controllable drug loading using micro-molding technology. In vivo trials in diabetic mice demonstrated similar hypoglycaemic effects of insulin-coated microneedles compared to subcutaneous injection, supporting the clinical translation of microneedle technique.
Over the years, scientists have been focused on the development of microneedle coating process to coat a broad range of therapeutic agents onto the surface of the solid microneedles for effective drug delivery. The precise dose control, content uniformity as well as large-scale production of coated microneedles are still the core issues that have been the interest of researchers in this topic. To this end, a repeatable method that involved a micro-molding process was demonstrated for mass fabrication of coated microneedles with homogeneous and controllable drug loading under mild conditions. In this system, the dissolvable drug carriers with precise dosage were first mounted onto the solid microneedles and then exposed to the high moisture condition to finally obtain the coated microneedle with uniform and precise drug loading. Using the microneedle molds with the volume of 4.71 nL, 8.24 nL, 10.47 nL, and 12.56 nL per cavity, the drug loadings were precisely controlled at 4.8 ng, 6.4 ng, 9.3 ng, and 13.5 ng per needle, with the standard deviation of 0.09, 0.01, 0.07, and 0.53%, respectively. Mechanical property tests showed that the coated microneedles are strong enough for reliable skin insertion, and with in vivo trials in diabetic mice, we further confirmed the similar hypoglycaemic effect of insulin-coated microneedles to subcutaneous injection. Taken together, the micro-molding-based fabrication process has practical merits in the mass production of coated microneedles with homogeneous and controllable drug loading, facilitating the clinical translation of the microneedle technique.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available